AMSA Pharm-free Scorecard 2010
B Duke University School of Medicine
City: Durham State: NC

Summary: Duke University School of Medicine has strong policies that could benefit from additional improvements. They have a model gift policy and of particular note, they have banned speakers bureau participation this year. However, they still have a samples policy that is lacking and could use some basic improvements such as removing samples from physician control. The new policies provided did not improve the low-scoring domains for this insitution. This institute needs to implement policy prohibiting distribution of pharmaceutical samples (or require institute approval of any sample distributing program), as well as improve policy regulating consulting relationships (require contracts or appropriate pay), disclosure (public disclosure or disclosure to patients), industry sales representatives (prohibit interaction between them an facutly), onsite and off site education (prohibit financial support or ensure material is independent of industry, prohibit support for travel).

Demographics: On average students spend 60% of their time training at Duke University Hospital, Durham Regional Hospital and Duke Raleigh Hospital, 20% at Private Diagnostic Clinic and Hospital Clinics on campus, and 20% at Private Diagnostic Clinic and Hospital Based Clinics off campus. Submitted policies apply to Duke Medicine facilities only.

Updates: Duke University School of Medicine submitted revised policies to the 2012-13 AMSA PharmFree Scorecard, their grade remains a B.


This institution has not granted permission for the posting of their policies on this website for illustrative purposes.

This institution's evaluation was last updated: 4/9/2013.


Gifts & Meals 3 Gifts, including promotional items, are not permitted. Meals cannot be provided directly at educational events.
Consulting relationships 2 All payments from outside sources, including consulting fees, must be disclosed to and subsequently reviewed by the institution, but only if they are greater than or equal to $600 per calendar year.
Industry-funded speaking relationships 3 Participation in speakers bureaus is prohibited. Presentation content must be independent of industry control.
Disclosure 2 All personnel must disclose financial ties with the pharmaceutical industry on an annual basis.
Pharmaceutical samples 1 The policy only covers where and how samples are stored.
Purchasing & Formularies 3 Committee members with conflicts of interest are required to recuse themselves from decision making.
Industry Sales Representatives 2 Industry representatives are allowed access to the SOM facilities but by appointment.
On-campus Education 2 The department chair or their delegate receives support for departmental educational events.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 Travel reimbursement cannot be received from industry directly.
Industry Support for Scholarships & Funds for Trainees 3 Scholarships and funds for trainees must be approved by the Office of Grants and Contracts. Educational funds must not be restricted by industry.
Medical school curriculum 3 All medical residents and fellows must complete trainings on the relationships between the pharmaceutical industry and medical staff, including the ways in which industry may influence medical-decision making.
Do the policies specify an oversight mechanism? Yes  This policy references oversight.
Are there explicit sanctions for noncompliance? Yes  This policy references sanctions.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)